Searchable abstracts of presentations at key conferences in endocrinology

ea0049gp172 | Obesity | ECE2017

Lipolytic effects of endogenous 3-iodothyronamine (T1AM) and synthetic analog SG-2 in vivo and in cultured adipocytes

Sabatini Martina , Rogowski Michael P , Alpergin Ebru S Selen , Assadi-Porter Fariba , Zucchi Riccardo , Chiellini Grazia

3-Iodothyronamine (T1AM) is a hormone like molecule structurally similar to TH, that has been reported to modulate energy metabolism by favoring lipid over glucose catabolism. To better understand the role played by T1AM on the regulation of lipid metabolism, in the present study we administered spontaneously obese mice with T1AM at two different dosages (10 and 25 mg/kg per day) for 7 days and the effects on body weight (BW) and lipid profiles were examined. In addition a flu...

ea0049gp223 | Thyroid 3 | ECE2017

Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG)

Bellusci Lorenza , Sabatini Martina , Nesi Giulia , Rapposelli Simona , Rossi Leonardo , Lenzi Paola , Fornai Francesco , Zucchi Riccardo , Chiellini Grazia

Endogenous TH metabolite 3-iodothyronamine (T1AM) and recently developed thyronamine-like synthetic analogues SG1 and SG2 have emerged as neuroprotective agents. Autophagy has proved to be an effective therapeutic approach for neurodegenerative diseases. Therefore we investigated whether these compounds can induce autophagy in human glioblastoma cells (U-87MG).Cultured U-87MG cells were initially treated with 1 μM T1AM, SG-1, SG-2 or vehicle for 30&...